Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Method of partitioning a database
Pressure assisted variable flow clean throat aerial retardant delivery system
Systems and methods for preventing cancer and treating skin lesions
Light projection unit, image reading device including same, and image forming apparatus including the image reading device
Measurement and testing system
Systems and methods for operation mode transition in wireless communications
Semiconductor device
  Randomly Featured Patents
Pyrazolopyridine compounds which have useful pharmaceutical utility
Water repellent slide fastener
Semiconductor decoder circuit having switching means for preventing counterflow
Universal error control coding scheme for digital communication and data storage systems
Process for low temperature, dry etching, and dry planarization of copper
Watch face
Original document reading device
Land grid array connector including heterogeneous contact elements
Manipulation of tocopherol content in transgenic plants
Halftone printing with different screens